Anal sac disease is a common condition encountered in first-opinion practice, yet treatment decisions can vary widely between clinicians. This session explores the pathogenesis, diagnosis and management of anal sac disorders, with a focus on balancing welfare, affordability and long-term outcomes through contextualised care. Using current evidence and practical case examples, the lecture will examine the causes of anal sacculitis, the role and limitations of medical management, and when surgical intervention should be considered. Delegates will gain confidence in discussing anal sacculectomy with owners, including surgical techniques, potential complications, costs and post-operative care. The session will also review the diagnosis and treatment of apocrine gland anal sac adenocarcinoma (AGASACA), including staging considerations, prognosis and the role of surgery in primary care settings. Attendees will leave with practical, evidence-based strategies for managing anal sac disease and supporting informed owner decision-making while maximising patient welfare.

Key Learning Objectives:

1. Describe the pathophysiology, risk factors and clinical presentation of common anal sac disorders encountered in first-opinion practice.
2. Compare medical and surgical management options for dogs with recurrent anal sac disease and evaluate their relative benefits and limitations.
3. Identify appropriate candidates for anal sacculectomy.
4. Explain the principles, risks and potential complications of anal sacculectomy to support informed owner consent and decision-making.
5. Evaluate treatment options and prognostic factors for dogs diagnosed with AGASACA, considering both patient welfare and client circumstances.
6. Formulate practical, evidence-based management plans for anal sac disease that balance clinical effectiveness, accessibility and welfare outcomes within a contextualised care framework.